|
Aug 6
|
Arcus Biosciences Reports Second-Quarter 2025 Financial Results and Provides a Pipeline Update
|
|
Aug 6
|
IonQ Announces Second Quarter Financial Results
|
|
Aug 6
|
Compugen Reports Second Quarter 2025 Results
|
|
Aug 6
|
US Health Department Ending Federal mRNA Vaccine Development
|
|
Aug 6
|
Cancer Antibody Drug Conjugates Market Research 2025-2031 | Pfizer, AstraZeneca, and Biotechs Like Miracogen Advance Cancer ADCs with Strategic Acquisitions and Innovative Pipelines
|
|
Aug 6
|
Trump says pharma tariffs to start small, then soar to 250%
|
|
Aug 5
|
Trump threatens 250pc tariffs on drug imports
|
|
Aug 5
|
EXCLUSIVE: Vivani Prioritizes Semaglutide-Based Implant After Promising Preclinical Data
|
|
Aug 5
|
SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes
|
|
Aug 4
|
Cellectis Reports Second Quarter 2025 Financial Results & Business Updates
|
|
Aug 4
|
Will These 5 Pharma, Biotech Bigwigs Surpass Q2 Earnings Forecasts?
|
|
Aug 4
|
AIM ImmunoTech Builds Positive Momentum and Reiterates Focus on Driving Ampligen® Clinical Development Toward Pancreatic Cancer Approval
|
|
Aug 3
|
Why Drug Prices for Some Big Medicines Will Remain High for a Longer Time
|
|
Aug 2
|
Drugmakers are pouring billions of dollars into new US manufacturing. It still won’t achieve all of Trump’s tariff goals
|
|
Aug 2
|
AstraZeneca Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
|
|
Aug 1
|
JNJ or AZN: Which Pharma Giant is a Better Buy Post Q2 Results?
|
|
Aug 1
|
Global Pharma Stocks Fall After Trump Demands Cuts in Drug Prices
|
|
Aug 1
|
Global Stocks to Watch: Novo Nordisk, AXA, Daimler Truck
|
|
Aug 1
|
European drugmakers fall after Trump raises stakes over US drug price cuts
|
|
Aug 1
|
Trump doubles down on Most Favored Nation plan to target drug prices
|